Back to All Collaborations

MenStar

Active Since: 2018

Multi-Company Partnership

Contributing to SDGs…

MenStar is a public-private partnership launched in 2018 that aims to reach men in sub-Saharan Africa with HIV diagnosis and treatment services.

MEMBER COMPANIES

PARTNER ORGANISATIONS

  • Bilateral Organisations

    US Presidents Emergency Plan for AIDS Relief (PEPFAR)

    Contribution

    Will invest in and support programming to reach men with HIV treatment

  • Global NGOs

    The Global Fund to Fight AIDS

    Contribution

    Will work with partners to adapt and learn from each other to more effectively reach men and boys with HIV services

  • Intergovernmental Organizations and Multilaterals

    UNITAID

    Contribution

    Supporting an HIV self-testing campaign aimed at young men in Kenya

  • Private foundation or development organization

    Children’s Investment Fund Foundation

    Contribution

    Supporting an HIV self-testing campaign aimed at young men in Kenya

    Elton John AIDS Foundation

    Contribution

    Supporting an HIV self-testing campaign aimed at young men in Kenya

    Prince Harry, Duke of Sussex

Objectives

MenStar seeks to expand the diagnosis and treatment of men living with HIV, with the goal of ending the AIDS epidemic by 2030, particularly in sub-Saharan Africa.

PEPFAR research has shown that men in countries with high HIV burdens, particularly those ages 24-35, continue to access HIV testing and treatment at low rates, which also fuels the spread of HIV among adolescent girls and young women.

At the 2018 International AIDS Conference, the Elton John AIDS Foundation and Prince Harry, Duke of Sussex, launched MenStar, a coalition to expand HIV diagnosis and treatment among men in developing countries. Gilead is a coalition member, along with PEPFAR, Unitaid, The Global Fund to Fight AIDS, Tuberculosis and Malaria, the Children’s Investment Fund Foundation and Johnson & Johnson. Partners of the coalition have pledged over $1.2 billion in funding.

PEPFAR seeks to reach an additional one million men with treatment and to support over 90 percent of men ages 24-35 to achieve viral suppression.

MenStar will support innovative approaches to deliver HIV services to men, in order to increase earlier uptake of HIV testing, linkage to care and viral suppression. Tactics will include targeted marketing, application of data analytics, demand creation and supply-side solutions. The initiative will also ensure that HIV treatment and services are scaled up to meet increased demand.

MenStar partners are planning an HIV self-testing campaign aimed at young men in Kenya. The coalition will also support HIV service delivery strategies aimed at men, such as dedicated men’s corners at health clinics and expanded clinic hours, as well as deeper community engagement to reach men.

The coalition partners seek to enhance each other’s work and accelerate progress towards achieving the 90-90-90 targets.

Quote
“It was a privilege to be able to launch such an important coalition of global partners as MenStar and for the Elton John AIDS Foundation to play such a pivotal role in its establishment. As a charity, we always try to pioneer new approaches to critical problems, then work with bigger players to optimize their impact. MenStar will give the Elton John AIDS Foundation the chance to do just that, to share learning quickly and complement one another’s activities.”
Sir Elton John
Founder, Elton John AIDS Foundation
“Gilead is proud to join the MenStar Coalition in its efforts to break the cycle of HIV transmission. As a company with a deep heritage in HIV, we know that increasing diagnosis and treatment rates can have a significant impact on helping to improve health and reduce new infections in at-risk communities around the world.”
Gregg Alton
Chief Patient Officer, Gilead Sciences

SDGs THE PARTNERSHIP CONTRIBUTES TO

SDG 3: Good Health and Wellbeing

  1. 3.3: Communicable Diseases & NTDs

SDG 17: Partnerships for the Goals